Cart
 
In Stock

Tobramycin, USP

Tobramycin, USP

CN¥0.00
Tobramycin

SKU: 02199697-CF

Synonyms
Nebramycin Factor 6; O-[3-Amino-3-deoxy-a-D-glucopyranosyl-(1?6)]-O-[2,6-diamino-2,3,6-trideoxy-a-D-ribohexopyranosyl-(1?4)]-2-deoxy-D-streptamine
CAS Number:
32986-56-4
Molecular Formula:
C18H37N5O9
Molecular Weight:
467.52 g/mol
Beilstein Registry Number:
1357507
EC Number:
251-322-5
MDL Number:
MFCD00077885
Product Description

Tobramycin

Application Notes

Tobramycin has been used:• to study the effect of tobramycin on bacteriophage infected biofilms• to study the effects of antibiotics on Pseudomonas aeruginosa strain• as a comparator antibiotic

Usage Statement

Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.

Specifications
SKU 02199697-CF
Alternate Names Nebramycin Factor 6; O-[3-Amino-3-deoxy-a-D-glucopyranosyl-(1?6)]-O-[2,6-diamino-2,3,6-trideoxy-a-D-ribohexopyranosyl-(1?4)]-2-deoxy-D-streptamine
Application Notes Tobramycin has been used:• to study the effect of tobramycin on bacteriophage infected biofilms• to study the effects of antibiotics on Pseudomonas aeruginosa strain• as a comparator antibiotic
Base Catalog Number 199697
Beilstein Registry Number 1357507
Biochemical Physiological Actions Tobramycin is an aminoglycoside. Mode of Action: Binds to 70S ribosomal subunit; inhibits translocation; elicits miscoding. Spectrum of Activity: Gram negative bacteria. Not effective against Enterococci.Tobramycin binds irreversibly to one of two aminoglycoside binding sites on the 30S ribosomal subunit, inhibiting bacterial protein synthesis. Tobramycin may also destabilize bacterial membranes by binding to 16S rRNA (ribosomal RNA). It inhibits translocation and elicits miscoding.Tobramycin is used to treat Pseudomonas aeruginosa lung infections and is used in combination with other antibiotics to treat urinary tract infections, gynecologic infections, peritonitis, endocarditis, pneumonia, sepsis, respiratory infections, osteomyelitis, and other soft-tissue infections. It is a potential therapy for sinus infections.
CAS # 32986-56-4
EC Number 251-322-5
Format Powder
Grade USP
Hazard Statements H315+H319+H317+H335
Molecular Formula C18H37N5O9
Molecular Weight 467.52 g/mol
pH Basic substance
Potency ≥900 µg/mg
Safety Symbol GHS08, GHS07
Solubility Water Solubility1000 mg/ml
Usage Statement Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
Vapor Pressure 2.37X10-21 mm Hg at 25 deg C (est)
Documents

Certificates of Analysis

Certificates of Analysis
English (United States)
Certificates of Analysis
English (United States)
Certificates of Analysis
English (United States)
Certificates of Analysis
English (United States)
Certificates of Analysis
English (United States)

Material Safety Data Sheet

Material Safety Data Sheet
English (United States)
Material Safety Data Sheet
Swedish (Sweden)
Material Safety Data Sheet
Spanish (Spain)
Material Safety Data Sheet
Portuguese (Portugal)
Material Safety Data Sheet
Norvegian (Norway)
Material Safety Data Sheet
Spanish (Mexico)
Material Safety Data Sheet
Japanese (Japan)
Material Safety Data Sheet
English (United Kingdom)
Material Safety Data Sheet
German (Germany)
Material Safety Data Sheet
French (France)
Material Safety Data Sheet
Finnish (Finland)
Material Safety Data Sheet
English (United Kingdom)
Material Safety Data Sheet
Chinese (China)
Material Safety Data Sheet
French (Canada)
Material Safety Data Sheet
English (Canada)
Material Safety Data Sheet
English (Australia)
Material Safety Data Sheet
English (United States)
Material Safety Data Sheet
English (United States)